Anteris Technologies Ltd (ASX: AVR) Announces U.S. IPO Launch
Anteris Technologies Ltd (ASX: AVR) launches a U.S. IPO for 14.8 million shares to advance its innovative medical solutions.
Anteris Technologies Ltd (ASX: AVR) launches a U.S. IPO for 14.8 million shares to advance its innovative medical solutions.
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
Visioneering Technologies, Inc. (ASX:VTI) has announced its intent to voluntarily delist from the ASX, seeking shareholder approval for the move.
Strata Minerals Limited (ASX:SMX) announces major advancements in gold, uranium, and rare earths exploration projects.
BTC Health announces an exclusive partnership with Corcym, set to enhance annual revenue by $3.6 million and improve profitability.
Recce Pharmaceuticals receives approval for a Phase 3 trial of RECCE® 327 in Indonesia for diabetic foot infections.
Elevate Uranium Limited (ASX:EL8) shares progress on exploration and upcoming U-pgrade™ demonstration plant in Namibia.
Saturn Metals Limited reports a fatal incident at Apollo Hill, prompting a suspension of operations and support for affected personnel.
Verbrec Limited secures a $4.2 million contract for the Electrical System Redevelopment Project at Inner Harbour, enhancing vital port infrastructure.
Tivan Limited secures a $7.4 million grant for the Speewah Fluorite Project, enhancing Australia’s critical minerals supply chain.